Seegene INC.
Jun B. Kim is an Executive Vice President with Seegene Inc. where he serves as the Global Head of Seegene OneSystem™ Business.
Joining Seegene as the Vice President of Procurement & Hardware Quality and soon being promoted to Senior Vice President of Global Supply Chain, Jun made significant impact to Seegene's top and bottom line, cash flow, and customer experience through sophisticated supply chain and operations strategies and has transformed the organizational culture through his leadership. Jun was promoted again to Executive Vice President and Global Head of Seegene OneSystem™ Business where he leads the company's emerging business.
Prior to joining Seegene, Jun has had an extensive global executive experience in Hewlett Packard, Cisco Systems, and Thermo-Fisher Scientific in the United States and Hong Kong. As a global operations leader and a General Manager running multi-billion dollar businesses, Jun has a track record of transforming supply chain and operations functions to be a competitive game changer for the business it serves to improve profitability and gain market share.
This person is not in any teams
Seegene INC.
1 followers
[INTRODUCING OUR COMPANY] The people of Seegene are on a purposeful mission to improve the world we live in. We aim to improve the quality of life for everyone globally by bringing molecular diagnostics to the masses. Molecular diagnostics is the most effective method to accurately diagnose ailments and is also the best way to diagnose them early which is when you can make the most difference in the recovery treatment. With industry-leading IP in molecular diagnostics reagent assays, we are dedicated to leveraging our unique technologies to increase our product portfolio, expand our market coverage, and lowering the total cost to serve our customers so that molecular diagnostics become a part of the fabric of everyone’s life and thus, improving the quality of life for everyone in the world. [OUR HISTORY AND OUR FUTURE] Since our founding in 2000, we have been steadfastly focused on molecular diagnostics. Currently, our product portfolio consists of over 250 molecular diagnostics reagent kits as well as a wide range of instruments and consumables that are sold globally. Testament to our expertise, when the pandemic started, Seegene was one of the first companies in the world to provide testing kits that were crucial in the fight against COVID. Today, we are a company with revenue of over $1 billion dollars and 65% gross margins. With 8 overseas entities, we generate a majority of our revenue outside of Korea. In keeping with our spirit of innovation and making a difference in the world, there are many exciting innovations being worked on at Seegene which will make it easier for the world to access the benefits of molecular diagnostics. We are transforming our business from a discrete reagent assay and instruments business to a platform business that will create new markets for molecular diagnostics and improve the quality of life for everyone. We hope that you will join us in our mission to make a meaningful difference in the world.